WINDLAS BIOTECH
|
WINDLAS BIOTECH Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 27.98 | 20.37 | 17.48 | 24.70 | 25.29 |
| CEPS(Rs) | 34.44 | 26.28 | 23.05 | 15.67 | 14.01 |
| DPS(Rs) | 5.50 | 4.00 | 3.50 | - | - |
| Book NAV/Share(Rs) | 213.99 | 190.89 | 180.31 | 310.59 | 327.03 |
| Tax Rate(%) | 24.52 | 25.27 | 16.41 | 28.38 | 34.28 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.39 | 11.74 | 11.25 | 12.79 | 12.61 |
| EBIT Margin(%) | 12.39 | 11.27 | 10.08 | 5.39 | 8.27 |
| Pre Tax Margin(%) | 12.22 | 11.12 | 9.78 | 5.08 | 7.50 |
| PAT Margin (%) | 9.22 | 8.31 | 8.17 | 3.64 | 4.93 |
| Cash Profit Margin (%) | 11.35 | 10.72 | 10.78 | 6.67 | 7.76 |
| Performance Ratios | |||||
| ROA(%) | 10.10 | 8.39 | 9.70 | 4.91 | 5.10 |
| ROE(%) | 13.78 | 10.76 | 12.87 | 7.62 | 8.04 |
| ROCE(%) | 18.34 | 14.39 | 14.88 | 9.85 | 11.81 |
| Asset Turnover(x) | 1.09 | 1.01 | 1.19 | 1.35 | 1.03 |
| Sales/Fixed Asset(x) | 2.69 | 2.87 | 2.68 | 3.24 | 4.01 |
| Working Capital/Sales(x) | 2.43 | 2.21 | 1.62 | 4.24 | 7.69 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.37 | 0.35 | 0.37 | 0.31 | 0.25 |
| Receivable days | 73.22 | 80.97 | 74.49 | 61.18 | 69.74 |
| Inventory Days | 39.61 | 47.47 | 39.24 | 38.74 | 37.93 |
| Payable days | 106.89 | 92.18 | 64.78 | 85.92 | 121.67 |
| Valuation Parameters | |||||
| PER(x) | 18.31 | 11.06 | 12.02 | - | - |
| PCE(x) | 14.88 | 8.57 | 9.11 | - | - |
| Price/Book(x) | 2.39 | 1.18 | 1.17 | - | - |
| Yield(%) | 1.07 | 1.78 | 1.67 | - | - |
| EV/Net Sales(x) | 1.64 | 0.87 | 0.75 | 0.02 | 0.05 |
| EV/Core EBITDA(x) | 11.29 | 6.36 | 5.92 | 0.11 | 0.35 |
| EV/EBIT(x) | 13.23 | 7.72 | 7.45 | 0.29 | 0.57 |
| EV/CE(x) | 2.30 | 1.11 | 0.72 | 0.02 | 0.05 |
| M Cap / Sales | 1.69 | 0.92 | 0.98 | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 22.97 | 10.12 | 8.96 | 30.03 | 7.02 |
| Core EBITDA Growth(%) | 30.56 | 18.71 | 2.33 | 31.47 | 2.78 |
| EBIT Growth(%) | 35.22 | 23.08 | 104.00 | -15.31 | -66.41 |
| PAT Growth(%) | 36.51 | 11.91 | 144.63 | -3.97 | -74.60 |
| EPS Growth(%) | 37.35 | 16.55 | -29.23 | -2.35 | -74.60 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | 0.02 | 0.16 | 0.13 |
| Current Ratio(x) | 2.51 | 2.92 | 4.06 | 2.08 | 1.34 |
| Quick Ratio(x) | 2.15 | 2.30 | 3.44 | 1.64 | 0.95 |
| Interest Cover(x) | 70.77 | 73.38 | 33.16 | 17.85 | 10.77 |
| Total Debt/Mcap(x) | - | - | 0.01 | - | - |
Compare Financial Ratios of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹2,222.6 Cr | -2.1% | -1.9% | 164.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹435,407.0 Cr | 0.3% | 0.2% | 46% | Stock Analytics | |
| DIVIS LABORATORIES | ₹157,489.0 Cr | -2.7% | -0.1% | 58.9% | Stock Analytics | |
| CIPLA | ₹117,443.0 Cr | -3% | -8.6% | 19% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,338.0 Cr | -0.1% | -3.4% | 7.2% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹99,244.9 Cr | 0.8% | 1.8% | 48.1% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -2.1% |
-1.9% |
164.6% |
| SENSEX | 0.7% |
2.5% |
17% |
You may also like the below Video Courses
